Literature DB >> 2530772

A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.

S M Miller1, G J Naylor, M Murtagh, G Winslow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530772     DOI: 10.1111/j.1600-0447.1989.tb07197.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


× No keyword cloud information.
  7 in total

Review 1.  Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.

Authors:  Juan Undurraga; Ross J Baldessarini
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

Review 3.  Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  K L Dechant; S P Clissold
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 4.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Janus Christian Jakobsen; Kiran Kumar Katakam; Anne Schou; Signe Gade Hellmuth; Sandra Elkjær Stallknecht; Katja Leth-Møller; Maria Iversen; Marianne Bjørnø Banke; Iggiannguaq Juhl Petersen; Sarah Louise Klingenberg; Jesper Krogh; Sebastian Elgaard Ebert; Anne Timm; Jane Lindschou; Christian Gluud
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630

5.  Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials.

Authors:  Ymkje Anna de Vries; Annelieke M Roest; Erick H Turner; Peter de Jonge
Journal:  Psychol Med       Date:  2018-09-28       Impact factor: 7.723

6.  Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

7.  The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.

Authors:  Michael A Sugarman; Amy M Loree; Boris B Baltes; Emily R Grekin; Irving Kirsch
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.